Sugentech Inc. (KOSDAQ:253840)
South Korea · Delayed Price · Currency is KRW 6,850.00
+50.00 (0.74%)
Sep 12, 2025, 3:30 PM KST
Sugentech Company Description
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally.
The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products.
The company was formerly known as Accugen Healthcare, Inc. and changed its name to Sugentech Inc. in October 2013.
Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea.
Sugentech Inc.
| Country | South Korea |
| Founded | 2011 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Employees | 144 |
| CEO | Jin Mi |
Contact Details
Address: 206, Techno 2-ro Daejeon South Korea | |
| Phone | 82 4 2364 5001 |
| Website | sugentech.com |
Stock Details
| Ticker Symbol | 253840 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7253840003 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Jin Mi | Chief Executive Officer |